X-group (possible homology)

1 cradle loop barrel

Ligands and drugs

75,139
Member domains
19,772
with ligand contacts (≤ 4 Å)
26.3% of members
14,767
with DrugDomain annotations
19.7% of members
8,189
with a DrugBank compound
10.9% of members

Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.

Chemical profile

ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.

960
Proteins with classified ligands
17
Superclasses bound (of 23)
9.4
Superclasses per 20 proteins
broader than 87% of the 256 X-groups with enough proteins to compare (median 7.6)

The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.

SuperclassProteinsExpected
0.25×observed / expected4×
RatioSignificance
Benzenoids15469.22.23×q < 0.0001
Organic acids and derivatives261146.51.78×q < 0.0001
Phenylpropanoids and polyketides3419.71.73×q = 5.5e-3
Organosulfur compounds3219.51.64×q = 0.01
Organic nitrogen compounds4630.21.52×q = 1.0e-2
Organoheterocyclic compounds155145.71.06×q = 0.47
Homogeneous non-metal compounds198203.70.97×q = 0.76
Nucleosides, nucleotides, and analogues245261.70.94×q = 0.30
Homogeneous metal compounds423464.60.91×q = 0.01
Organic oxygen compounds144188.50.76×q = 5.4e-4
Hydrocarbons56.60.76×q = 0.76
Mixed metal/non-metal compounds1419.90.70×q = 0.28
Lipids and lipid-like molecules26105.40.25×q < 0.0001
Organic salts11.01.02×not tested
Organohalogen compounds22.70.74×not tested
Organometallic compounds11.40.74×not tested
Alkaloids and derivatives13.20.31×not tested
enriched (q < 0.05)depleted (q < 0.05)not significantnot tested (expected < 5)

Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.

DrugBank compounds

DrugBankPDB ligandNameDomains
DB03147FADFlavin adenine dinucleotide471
DB00141NAGN-Acetylglucosamine369
DB00114PLPPyridoxal phosphate173
DB03247FMNFlavin mononucleotide162
DB01264017Darunavir161
DB02078PG5Triglyme98
DB03461NAPNicotinamide adenine dinucleotide phosphate96
DB00171ATPATP71
DB01232ROCSaquinavir65
DB09459TLAL-tartaric acid62
DB03345BMEMercaptoethanol59
DB00701478Amprenavir54
DB16833ADPAdenosine disphosphate43
DB00224MK1Indinavir36
DB068410G6[(2R)-1-[(2S)-2-[[(2S,3S)-1-Chloro-6-(diaminomethylideneamino)-2-hydroxyhexan-3-yl]carbamoyl]pyrrolidin-1-yl]-1-oxo-3-phenylpropan-2-yl]azanium35
DB00503RITRitonavir33
DB02313AG7Ethyl (4R)-4-{[(2R,5S)-2-(4-fluorobenzyl)-6-methyl-5-{[(5-methyl-1,2-oxazol-3-yl)carbonyl]amino}-4-oxoheptanoyl]amino}-5-[(3S)-2-oxo-3-pyrrolidinyl]pentanoate32
DB03913F42Coenzyme F42031
DB188347YYEnsitrelvir31
DB01694TARD-tartaric acid29

Most frequently bound compounds

PDB ligandNameDomains in contact
MGmetalMAGNESIUM ION3,110
CLCHLORIDE ION1,352
ZNmetalZINC ION1,297
CAmetalCALCIUM ION1,242
NAmetalSODIUM ION923
FADFLAVIN-ADENINE DINUCLEOTIDE522
NAG2-acetamido-2-deoxy-beta-D-glucopyranose511
KmetalPOTASSIUM ION277
MNmetalMANGANESE (II) ION241
BENBENZAMIDINE197
MGD2-AMINO-5,6-DIMERCAPTO-7-METHYL-3,7,8A,9-TETRAHYDRO-8-OXA-1,3,9,10-TETRAAZA-ANTHRACEN-4-ONE GUANOSINE DINUCLEOTIDE189
IODIODIDE ION187
017(3R,3AS,6AR)-HEXAHYDROFURO[2,3-B]FURAN-3-YL(1S,2R)-3-[[(4-AMINOPHENYL)SULFONYL](ISOBUTYL)AMINO]-1-BENZYL-2-HYDROXYPROPYLCARBAMATE168
PLPPYRIDOXAL-5'-PHOSPHATE166
FMNFLAVIN MONONUCLEOTIDE160
OHXosmium (III) hexammine145
4WI(1R,2S,5S)-N-{(1E,2S)-1-imino-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-6,6-dimethyl-3-[3-methyl-N-(trifluoroacetyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide121
PG51-METHOXY-2-[2-(2-METHOXY-ETHOXY]-ETHANE105
NAPNADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE93
U1H[4-(trifluoromethyl)phenyl]methanamine92